FR2313923A1 - Nouvelle association douee notamment d'une activite analgesique, myorelaxante, anxiolytique et anti-inflammatoire - Google Patents

Nouvelle association douee notamment d'une activite analgesique, myorelaxante, anxiolytique et anti-inflammatoire

Info

Publication number
FR2313923A1
FR2313923A1 FR7518532A FR7518532A FR2313923A1 FR 2313923 A1 FR2313923 A1 FR 2313923A1 FR 7518532 A FR7518532 A FR 7518532A FR 7518532 A FR7518532 A FR 7518532A FR 2313923 A1 FR2313923 A1 FR 2313923A1
Authority
FR
France
Prior art keywords
contg
noramidopyrin
chlormezanone
meprobamate
sodium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7518532A
Other languages
English (en)
French (fr)
Other versions
FR2313923B1 (enrdf_load_stackoverflow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LUCIEN LABORATOIRES
Original Assignee
LUCIEN LABORATOIRES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LUCIEN LABORATOIRES filed Critical LUCIEN LABORATOIRES
Priority to FR7518532A priority Critical patent/FR2313923A1/fr
Publication of FR2313923A1 publication Critical patent/FR2313923A1/fr
Application granted granted Critical
Publication of FR2313923B1 publication Critical patent/FR2313923B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7518532A 1975-06-13 1975-06-13 Nouvelle association douee notamment d'une activite analgesique, myorelaxante, anxiolytique et anti-inflammatoire Granted FR2313923A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7518532A FR2313923A1 (fr) 1975-06-13 1975-06-13 Nouvelle association douee notamment d'une activite analgesique, myorelaxante, anxiolytique et anti-inflammatoire

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7518532A FR2313923A1 (fr) 1975-06-13 1975-06-13 Nouvelle association douee notamment d'une activite analgesique, myorelaxante, anxiolytique et anti-inflammatoire

Publications (2)

Publication Number Publication Date
FR2313923A1 true FR2313923A1 (fr) 1977-01-07
FR2313923B1 FR2313923B1 (enrdf_load_stackoverflow) 1978-10-06

Family

ID=9156485

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7518532A Granted FR2313923A1 (fr) 1975-06-13 1975-06-13 Nouvelle association douee notamment d'une activite analgesique, myorelaxante, anxiolytique et anti-inflammatoire

Country Status (1)

Country Link
FR (1) FR2313923A1 (enrdf_load_stackoverflow)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9499480B2 (en) 2006-10-12 2016-11-22 Bhi Limited Partnership Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006085149A2 (en) 2004-12-22 2006-08-17 Neurochem (International) Limited Methods and compositions for treating amyloid-related diseases

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9499480B2 (en) 2006-10-12 2016-11-22 Bhi Limited Partnership Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
US10238611B2 (en) 2006-10-12 2019-03-26 Bellus Health Inc. Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
US10857109B2 (en) 2006-10-12 2020-12-08 Bellus Health, Inc. Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
US11020360B2 (en) 2006-10-12 2021-06-01 Bellus Health Inc. Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

Also Published As

Publication number Publication date
FR2313923B1 (enrdf_load_stackoverflow) 1978-10-06

Similar Documents

Publication Publication Date Title
ES538807A0 (es) Un procedimiento para la produccion de un complejo covalentemente unido de inhibidor de alfa-1-proteinasas con un polimero soluble en agua.
ZA817297B (en) Imidazo(1,2-a)pyridine derivatives useful in therapy and their preparation
ATE190064T1 (de) Kombination therapeutische nukleoside mit weiteren therapeutisch wirksamen komponenten.
PH24437A (en) Method for the treatment of withdrawal symptoms associated with smoking cessation and preparations for use in said method
EG19912A (en) The use of the active substance azelastine in combatting psoriasis disorders and inflammatory disorders
ES2061989T3 (es) Uso de esteres alquilicos del acido piroglutamico para la fabricacion de un medicamento para el tratamiento de la ictiosis.
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
DE3478749D1 (en) Covalently bound heparin - antithrombin-iii complex, method for its preparation and its use for treating thromboembolism
IT1189298B (it) Procedimento per produrre i glicosa minoglicani dermatansolfato ed eparan-solfato sostanzialmente puri e loro impiego farmaceutico
FR2313923A1 (fr) Nouvelle association douee notamment d'une activite analgesique, myorelaxante, anxiolytique et anti-inflammatoire
IE38943B1 (en) Pyrroles and process for their manufacture
AU1395583A (en) Use of oleanolic acid for ulcer treatment
DE3467705D1 (en) Use of 4,5'-azo-bis-salicylic acid for the manufacture of a medicament for the treatment of inflammatory disorders in the intestine
Š? ÁVA et al. Salazopyrin in the treatment of scleroderma
FR2155927A1 (en) 1-phenylcyclo hexane carboxylic acid esters - with antispasmodic and anticholinergic activity
GR852408B (enrdf_load_stackoverflow)
DE3665126D1 (en) Preparation on the basis of a mixture
FR2320098A1 (fr) Nouveaux derives de la thiazilo (3,4-b) isoquinoleine, leur preparation et les compositions qui les contiennent
DE3260567D1 (en) Analgesic potentiation
DK0673646T3 (da) Anvendelse af deoxyspergualin til fremstilling af et lægemiddel til behandling af inflammatorisk-hyperreaktive sygdomme
FR2392972A1 (fr) Nouveaux analogues de 11-desoxy-prostaglandines, leur procede de preparation et medicament les contenant
JPS5249654A (en) Preliminary treatment of human and animal excrements with bacteria in intestines
NL7603491A (en) N-nicotinoyl-4-amino benzoic acid derivs - in compns for promoting cerebral blood flow esp in the elderly
AU514653B2 (en) Pharmaceutical preparations forthe treatment of disorders in calcium metabolism
SE8303400D0 (sv) Azo-bis-salicylsyra och salt derav samt deras farmaceutiska beredning och anvendning

Legal Events

Date Code Title Description
ST Notification of lapse